VTB Capital selects Quantifi for OTC Analytics, Pricing and Portfolio Valuation

November 9, 2011
  • Firm to utilize Quantifi for fast and accurate derivatives analytics

London and New York (9th November 2011) - Quantifi, a leading provider of analytics, trading and risk management solutions for the global OTC markets, today announced that ​Leading Russian Investment Bank, VTB Capital has licensed Quantifi XL as their front-office tool for OTC analytics, pricing and portfolio valuation.

VTB Capital, the investment business of VTB Group, is a leader in global investment banking. VTB Capital offers a full range of investment banking products and services. The company focuses on arranging operations in the debt, equity, global commodities markets, developing investment and asset management and advising clients on M&A and ECM deals in Russia and abroad. To support their recently formed credit derivatives and hybrids trading desks, VTB Capital needed access to market-validated models and analytics. VTB Capital selected Quantifi for ease of use and the firm’s established track record.

 


 

“Quantifi’s expertise and ability to deliver a robust tool set for OTC analytics and client pricing were key factors in our decision. Quantifi has already reduced our operational costs and increased our business flexibility by allowing us to focus internal development on other strategic projects.”

Stathis Margonis, Head of Credit Derivatives and Hybrids Trading of VTB Capital


 

“We looked to implement a portfolio valuation solution that increased accuracy and flexibility while at the same time minimised operational risk,” said Stathis Margonis, Head of Credit Derivatives and Hybrids Trading of VTB Capital, “Quantifi’s expertise and ability to deliver a robust tool set for OTC analytics and client pricing were key factors in our decision. Quantifi has already reduced our operational costs and increased our business flexibility by allowing us to focus internal development on other strategic projects”

Quantifi XL provides pricing and structuring for even the most complex OTC products in a familiar and flexible Excel environment. Comprehensive, powerful, and easy-to-use functions cover the simplest calculations to the most advanced pricing and sensitivity analysis. Extensive online help, tutorials and worksheet examples make getting started and using Quantifi XL simple and intuitive.

"We are extremely proud of our new relationship with VTB Capital and also having added a leading emerging markets bank to our growing global client base," said Rohan Douglas, CEO of Quantifi. "Many of VTB’s traders were Quantifi users at prior institutions and the addition of VTB to our client base is a testament to our products and services and the trust placed in us. We look forward to working with VTB as we continue to evolve and improve our products to stay ahead of the latest market developments.”

 


 

About VTB Capital

VTB Capital, the Investment Business of VTB Group, is one of the three strategic business arms of VTB Group, along with the corporate and retail businesses. Since its foundation in 2008, VTB Capital has taken part in more than 184 ECM and DCM deals, which were instrumental in attracting more than USD 88bn worth of investments in Russia and CIS.

VTB Capital offers a full range of investment banking products and services, focusing on arranging operations in the debt, equity, global commodities markets, developing investment and asset management, advising clients on M&A and ECM deals in Russia and abroad. VTB Capital operates in Moscow, London, Singapore, Dubai and Hong Kong, with headquarters in Moscow.

For further information, please visit VTB Capital